RIL
ACAD icon

Rothschild Investment LLC’s Acadia Pharmaceuticals ACAD Stock Holding History

Rothschild Investment LLC’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.63K Buy
262
+110
+72% +$2.42K ﹤0.01% 2121
2026
Q1 		$3.38K Sell
152
-63
-29% -$1.51K ﹤0.01% 2266
2025
Q4 		$5.74K Buy
215
+25
+13% +$597 ﹤0.01% 1818
2025
Q3 		$4.05K Sell
190
-20
-10% -$473 ﹤0.01% 1802
2025
Q2 		$4.53K Sell
210
-10
-5% -$186 ﹤0.01% 1564
2025
Q1 		$3.65K Buy
220
+50
+29% +$908 ﹤0.01% 1585
2024
Q4 		$3.12K Buy
170
+55
+48% +$888 ﹤0.01% 1550
2024
Q3 		$1.77K Buy
115
+75
+188% +$1.25K ﹤0.01% 1795
2024
Q2 		$650 Buy
40
+30
+300% +$484 ﹤0.01% 1868
2024
Q1 		$185 Buy
+10
New +$248 ﹤0.01% 1780

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rothschild Investment LLC's ACAD Position: Q2 2026 in Review

Rothschild Investment LLC increased its Acadia Pharmaceuticals (ACAD) stake by 72% in Q2 2026, buying an estimated $2.42K and bringing the position to 262 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Rothschild Investment LLC first reported a position in ACAD in Q1 2024 and has held it in 10 quarters since. 353 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Rothschild Investment LLC held 262 shares of Acadia Pharmaceuticals worth $6.63K as of Q2 2026.
  • Rothschild Investment LLC bought 110 Acadia Pharmaceuticals shares in Q2 2026, an estimated $2.42K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2121 holding.
  • Rothschild Investment LLC first reported a position in Acadia Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 353 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.